Workflow
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
MRNAModerna(MRNA) zacks.com·2024-05-28 15:41

Despite the declining top line, shares of Moderna (MRNA) continue to soar thanks to its encouraging pipeline updates and potential product launches over the next few years. The company boasts of a pipeline of more than 40 mRNA-based investigational candidates across different stages of development, targeting multiple indications, including cancer and cardiovascular. Being one of the handful of makers of a COVID-19 vaccine, Moderna reaped the benefits of the COVID-19 pandemic, allowing it to strengthen its c ...